“The problem in issuing the existing smallpox/monkeypox vaccine an EUA, is that it was already approved by the FDA, even though it has not been tested in the public much beyond the initial trials conducted by the drug company.
According to Dr. Meryl Nass, that may not stop them from figuring out a way to get the FDA to issue them an EUA to avoid legal liability…”